title: Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
abstract: In the first quarter of 2008, Deals coverage by Thomson Pharma (www.thomsonpharma.com) included data on approximately 350 new deals within the pharmaceutical industry. This article highlights some of the most valuable and notable deals from this period, and includes details of agreements established by Takeda, agreements formed between Isis and Genzyme and between Acceleron and Celgene, and other deals by major players in the pharmaceutical industry, including Pfizer, sanofi-aventis, Merck & Co, GlaxoSmithKline, Amgen and Eli Lilly.
authors.affiliation: Thomson Scientific, 77 Hatton Garden, London, UK. jaya.shumoogam@thomson.com
authors.forename: Jaya
authors.initials: J
authors.lastname: Shumoogam
authors.forename: Asma
authors.initials: A
authors.lastname: Al-Shamahi
mesh_terms: D035843:Biomedical Research / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D003299:Cooperative Behavior; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D006801:Humans